AXDX - Accelerate Diagnostics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue4,177246147122
Cost of Revenue1,002---
Gross Profit3,175246147122
Operating Expenses
Research Development22,30129,56427,14219,526
Selling General and Administrative45,05837,18318,55410,695
Non Recurring----
Others----
Total Operating Expenses68,36166,74745,69631,109
Operating Income or Loss-64,184-66,501-45,549-30,987
Income from Continuing Operations
Total Other Income/Expenses Net6493945154
Earnings Before Interest and Taxes-64,184-66,501-45,549-30,987
Interest Expense---4-7
Income Before Tax-63,535-66,107-45,498-30,933
Income Tax Expense493267--
Minority Interest----
Net Income From Continuing Ops-64,028-66,374-45,498-30,933
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-64,028-66,374-45,498-30,933
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-64,028-66,374-45,498-30,933